Shuji Murakami Selected Research

Body Weight (Weight, Body)

12/2018	Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
11/2017	Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
3/2007	Changes in estrogen receptors alpha and beta expression in the brain of mice exposed prenatally to bisphenol A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuji Murakami Research Topics

Disease

47	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2010
19	Neoplasms (Cancer) 01/2024 - 08/2012
12	Disease Progression 02/2024 - 05/2009
9	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2010
8	Pneumonia (Pneumonitis) 03/2024 - 02/2010
5	Adenocarcinoma 01/2024 - 01/2010
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2011
4	Tuberculosis (Tuberculoses) 06/2021 - 07/2007
4	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2017
4	Carcinoma (Carcinomatosis) 10/2017 - 01/2011
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2012
3	Fatigue 12/2019 - 02/2010
3	Body Weight (Weight, Body) 12/2018 - 03/2007
3	Neutropenia 05/2017 - 02/2010
2	Thymoma (Thymic Carcinoma) 02/2024 - 07/2016
2	Microsatellite Instability 01/2023 - 03/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2018
2	Diarrhea 01/2022 - 02/2013
2	Febrile Neutropenia 03/2013 - 02/2013
2	Rheumatoid Arthritis 03/2009 - 02/2007
1	Small Cell Carcinoma 01/2024
1	Vascular Remodeling 01/2024
1	Brain Neoplasms (Brain Tumor) 05/2023
1	Colitis 01/2022
1	Exanthema (Rash) 01/2022
1	Dermatitis 01/2022
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 12/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2020
1	Cough 12/2019
1	Chest Pain (Chest Pains) 12/2019
1	Vision Disorders (Hemeralopia) 07/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2019
1	Autoimmune Diseases of the Nervous System 01/2019

Drug/Important Bio-Agent (IBA)

10	Immune Checkpoint InhibitorsIBA 05/2024 - 03/2020
10	durvalumabIBA 03/2024 - 11/2017
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 02/2010
8	PlatinumIBA 05/2024 - 11/2017
8	nedaplatinIBA 01/2018 - 01/2011
7	pembrolizumabIBA 02/2024 - 12/2020
7	NivolumabIBA 01/2024 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
6	B7-H1 AntigenIBA 01/2024 - 11/2017
6	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2019
6	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2010
5	Cisplatin (Platino)FDA LinkGeneric 04/2022 - 01/2010
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2017 - 02/2010
3	Bevacizumab (Avastin)FDA Link 04/2024 - 01/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 02/2010
3	Pemetrexed (MTA)FDA Link 01/2023 - 12/2019
3	EnzymesIBA 04/2022 - 05/2008
3	LigandsIBA 03/2022 - 10/2019
3	Interferon-gamma (Interferon, gamma)IBA 03/2022 - 05/2008
2	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 02/2024
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2009
2	osimertinibIBA 10/2023 - 01/2019
2	Anaplastic Lymphoma KinaseIBA 01/2023 - 09/2010
2	AntibodiesIBA 12/2020 - 01/2013
2	Alanine Transaminase (SGPT)IBA 07/2019 - 02/2010
2	Docetaxel (Taxotere)FDA Link 01/2019 - 05/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 08/2014
2	ParaffinIBA 10/2017 - 08/2014
2	Formaldehyde (Formol)FDA Link 10/2017 - 08/2014
2	Gefitinib (Iressa)FDA Link 01/2012 - 02/2010
2	Heme Oxygenase-1IBA 01/2010 - 08/2008
2	AntigensIBA 05/2009 - 03/2009
2	Tuberculin (PPD)IBA 03/2009 - 07/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2009 - 02/2009
1	atezolizumabIBA 05/2024
1	130-nm albumin-bound paclitaxelIBA 04/2024
1	Albumin-Bound Paclitaxel FDA Link 04/2024
1	lenvatinibIBA 02/2024
1	MucinsIBA 01/2024
1	Circulating Tumor DNAIBA 01/2024
1	brigatinibIBA 01/2024
1	eribulin FDA Link 01/2024
1	lorlatinibIBA 05/2023
1	Therapeutic UsesIBA 01/2023
1	CytokinesIBA 01/2023
1	Cytochrome P-450 CYP3AIBA 04/2022
1	Aprepitant (Emend)FDA Link 04/2022
1	AntiemeticsIBA 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2022
1	Interleukin-8 (Interleukin 8)IBA 03/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020
1	Aspartic Acid (Aspartate)FDA Link 07/2019
1	CrizotinibIBA 07/2019
1	AutoantibodiesIBA 01/2019
1	RamucirumabIBA 01/2019

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 05/2024 - 01/2010
19	Therapeutics 04/2024 - 07/2007
8	Chemoradiotherapy 03/2024 - 11/2017
4	Combination Drug Therapy (Combination Chemotherapy) 01/2013 - 02/2010
3	Radiotherapy 01/2024 - 05/2017
3	Immunotherapy 01/2023 - 12/2020
2	Aftercare (After-Treatment) 06/2021 - 01/2012
2	Adjuvant Chemotherapy 01/2018 - 11/2016
2	Operative Surgical Procedures 11/2016 - 08/2012
1	Molecular Targeted Therapy 10/2017